A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections
Background. At the present time, COVID-19 vaccines are at the testing stage, and an effective treatment for COVID-19 incorporating appropriate safety measures remains the most significant obstacle to be overcome. A strategic countermeasure is, therefore, urgently required. Aim. This study aims to ev...
Saved in:
Similar Items
-
Studi Penggunaan Lopinavir/Ritonavir Pada Pasien Covid-19 Derajat Ringan-Sedang Dengan Komorbid Hipertensi Dan Diabetes Melitus Di Rumah Sakit Bhayangkara H.S Samsoeri Mertojoso Surabaya
by: Muhammad Nashrullah, '-
Published: (2021) -
A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections
by: Purwati, Purwati, et al.
Published: (2021) -
The Potency of Hematopoietic Stem Cells (HSCs) and Natural Killer (NK) Cells as A Therapeutic of SARS-CoV-2 Indonesia Isolates Infection by Viral Inactivation (In Vitro Study)
by: Purwati, et al.
Published: (2020) -
Pengetahuan, Sikap, dan Perilaku Masyarakat terhadap Infodemik Penggunaan Azithromycin dan Ivermectin selama Masa Pandemi COVID-19
by: Mikhael Ardi Kristiawan, -, et al.
Published: (2022) -
An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia
by: Purwati, et al.
Published: (2021)